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Congenital heart defects (CHDs) are one of the most prevalent types of birth defects in the 
United States. Both environmental and genetic components are known to contribute to the 
development of CHDs. One of the ways toxins present in the environment cause CHDs is by 
disrupting the expression of genes known to be vital in normal cardiac morphogenesis. Thus, the 
identification of both toxins that cause birth defects in cardiac development and genes expressed 
during heart development is crucial in order to fully understand the relationship between 
environment and genetics as they relate to CHD. Due to their external development, high 
fecundity, and knowledge of their genome sequence, zebrafish are an excellent model organism 
in which to study both gene expression and the role of toxins in cardiac development. Further, 
many zebrafish genes are orthologous to those found in humans, and thus allow genetic findings 
in zebrafish to be extrapolated to research on human disease and physiology. In order to identify 
genes expressed in the heart during development a single-cell RNA sequencing (scRNAseq) 
study was performed by the Bloomekatz laboratory, which preliminarily identified a novel gene 
ccdc141 (coiled-coil domain containing 141) as having a role in cardiac development and 
possibly CHDs. Here, we have sought to validate these preliminary studies by determining the 
spatial and temporal gene expression of ccdc141 throughout the early stages of zebrafish 
development. In situ hybridization (ISH) procedures utilized for this purpose are ideal for 
visualizing gene expression as the entire organism can be viewed at once. Our hypothesis is that 
ccdc141 will be expressed in the heart of developing zebrafish. Results obtained through ISH 
 v 
show that ccdc141 is expressed in the heart and in cardiac precursors, as well as in somites and 
the head. These data will aid in further studies to determine the function of ccdc141 in 
development. In addition to our work on identifying the gene expression of ccdc141, we created 
an extensive table of environmental toxins that disrupt cardiac development in zebrafish and may 
contribute to the pathogenesis of CHD in humans.  
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Congenital heart defects (CHDs) are one of the most common forms of birth defects, 
affecting approximately 1% of live births and are a leading cause of infant mortality (5). Defects 
in the heart valves and septa formation, aortic and pulmonary stenosis, and Tetralogy of Fallot 
are a few examples of the different types of congenital heart defects, all of which can cause 
lifelong problems for patients (5). Oftentimes, if the birth defect is not severe enough to cause 
immediate problems at birth, it is not discovered until later in the child’s life when further 
medical problems arise (6). Typically, patients experience pain or breathlessness during exercise, 
abnormal heart sounds, and fatigue, but all of these symptoms are nonspecific and could be the 
result of any number of other diseases, making CHD difficult to diagnose (7). This study seeks to 
analyze gene expression and exposure to environmental toxins in zebrafish as a first step towards 
a better understanding of the causes and mechanisms of CHDs in humans.  
In order to determine the etiology of CHD, it is necessary to analyze the expression of 
genes that play a role in cardiogenesis. Gene expression is the foundation of development and 
cellular differentiation as different genes are regulated (turned on or off) based on the needs of 
the cell during different stages of development or in response to environmental factors, including 
environmental toxicants. Thus, the study of gene expression is vital in determining the etiology 
of diseases, including CHDs. Results collected from studying how and when a gene is expressed 
in normal development can be used as a control when looking at gene expression and function in 
diseased cells (8). By comparing the temporal and spatial gene expression patterns of a diseased 
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cell to that of a developmentally normal cell, we can identify which specific gene(s) of the 
diseased cell are incorrectly regulated and thus causing disease – an important step toward 
determining the function of the gene and ultimately new treatments and cures, like genetic 
therapies (9, 10). 
 
I. Zebrafish as Model Organism 
 A model organism is one that can be used to study a wide range of biological disciplines 
(11). They are well studied organisms that are easily manipulated and maintained in a laboratory 
setting and offer the benefit of having gene orthologs in other species (12). In particular, model 
organisms are good for studying the molecular underpinnings of human physiology that cannot 
be sufficiently studied due to ethical or practical considerations. Model organisms are essential in 
biological research and offer a wealth of information, from which experimental results can be 
extrapolated to other species.  
 Zebrafish (Danio rerio) are a particularly valuable model organism for studying a variety 
of subjects, from fundamental biological processes such as gene expression, to modeling 
clinically relevant human diseases. Importantly, the entire genome of zebrafish has been 
sequenced, facilitating the study and identification of genes and genetic mutations. Zebrafish are 
orthologous to a variety of other organisms, including humans, in which around 70% of genes 
have a zebrafish ortholog (12). ccdc141, the gene of interest in this experiment, is one of those 
orthologs. Thus, the function of particular genes whose function in other organisms is unclear 
can be studied in zebrafish (13). Orthologous genes can be manipulated and mutated to observe 
how physiological, developmental and cellular processes in zebrafish are affected; these results 
can then be extrapolated to humans. This is particularly important in this study, as the main goal 
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is to determine the expression of ccdc141 in zebrafish, a crucial first step in determining its 
function(s) in human development. 
Zebrafish embryos have other unique characteristics that make them ideal model 
organisms. Principally, zebrafish embryos are transparent and undergo external development, 
allowing tissue structures, gene expression, and other processes to be easily observed (14). It also 
allows the researcher to easily access the embryo for genome manipulation and for live imaging. 
External development allows for the study of development immediately following fertilization 
and throughout development, since development occurs outside of the mother, a significant 
aspect not afforded by other species. Further, zebrafish have high fecundity, and thus are able to 
produce large numbers of embryos at once, providing more material for study, as opposed to an 
organism that produces only one or two embryos at a time (14). Hundreds to thousands of 
zebrafish can be stored in one room, saving both space and money. Lastly, zebrafish have a very 
quick maturation period, allowing us to observe embryonic development in its entirety much 
more quickly than could be done with organisms that take weeks or months to fully develop, 
































Figure 1. Stages of zebrafish development highlighted in this study. At 50% 
epiboly, the animal and vegetal poles are 50% covered by the blastoderm, which is 
uniform in thickness. Epiboly, the movement of blastoderm cells as they surround 
the yolk and enclose the blastopore then occurs, completely covering the yolk by the 
bud stage (as indicated by the prominence of the tailbud.) At 3 somites (s) stage, the 
somitic furrow has formed and the polster, the hatching gland rudiment underlying 
the forebrain, is prominent. In the 10s stage, the otic placode and trunk somites are 
visible. Linear heart tube elongation and initiation of a heartbeat are characteristics of 
26 hours post fertilization (hpf), as well as pigmentation of the skin and retina. 
Motility begins at 36 hpf, and the atria and ventricle become distinct; cardiac looping 
is also occurring. By 48 hpf, the pectoral buds are elongated, heart looping is 




Congenital heart diseases have a well-known genetic component – babies are more likely 
to be born with a heart defect if the mother or another member of its immediate family also 
suffers from a CHD (7). ccdc141 (coiled-coil domain containing 141), a protein coding gene 
located on chromosome 9 of zebrafish, could be one of the genes involved in the development of 
CHDs. ccdc141 was identified through the single cell RNA sequencing (scRNA-seq) of mouse 
mesoderm cells, including progenitors and differentiated cardiomyocytes. A t-distributed 
stochastic neighbor embedding (t-SNE) visualization of this data clusters cells with similar gene 
expression patterns closer to one another and farther away from cells with varying gene 
expression (Figure 2A). Clusters 1 and 2 are the clusters of cardiomyocyte cells. Analysis of 
genes expressed in these clusters identified ccdc141 as a gene highly expressed in these clusters 
and not in the other clusters.  
 ccdc141 has previously been implicated in the regulation of heart rate (15, 16). A 
genome wide association study identified five previously unknown loci associated with heart rate 
regulation including ccdc141 (15). Observed via electrocardiogram (ECG), results showed that 
the associated SNP allele ‘A’ close to ccdc141 is associated with a prolonged QRS duration, 
which slows the spread of ventricular depolarization, and increased heart rate. In fact, individuals 
with the associated SNP allele showed the highest increase in heart rate of all alleles identified 
(15).  
Additionally, ccdc141 is has been shown to be involved in cellular migration in the 
nervous system, where the gene is heavily expressed. Due to this expression pattern, several 
studies have been conducted to determine the role of ccdc141 in development and disease of the 
nervous system in humans. Mutations in cdc141 have been identified in the development of 
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hypogonadotropic hypogonadism, a disease characterized by the dysfunction of the gonads (17). 
In this disease, ccdc141 reduces the movement of migrating GnRH neurons, impairing 
gonadotropic releasing hormone (18).  
The preliminary data described above regarding the role of ccdc141 in the heart indicates 
that ccdc141 variants/mutations could be involved in the development of CHDs. Based on these 
data, we will examine the dynamics of ccdc141 expression in an attempt to shed further light on 
its function in the heart and its possible role in CHD. Use of the zebrafish ccdc141 gene is ideal 
in this study, as it is orthologous to the human ccdc141 gene; therefore, data collected regarding 






















































Figure 2. t-distributed stochastic neighbor embedding (t-SNE) plot of ccdc141. t-SNE is 
a dimensionality reduction algorithm mapped in two dimensions on a scatter plot. It is used 
in single cell RNA-seq to visualize similar groups of cells. Each dot represents a single cell, 
and cells are grouped together based on their transcriptional profiles. Cells with similar 
profiles, or similar gene expression, are grouped together into clusters, and the closer the 
clusters are to one another, the more similar their transcriptional profiles as well. A) Clusters 
of all cell types in mouse. Clusters are differentiated by number and color as noted in the 
legend. B) Range of expression of ccdc141 in the clusters. As the cell colors move from red 
to magenta (range 0-26) as shown in the figure legend, the expression of ccdc141 in those 
cells increases. It is highly expressed in clusters 1 and 2, corresponding to cells of the heart, 






















Figure 3. Location of ccdc141 on chromosome 9 of zebrafish. ccdc141 is located 
between 43,074,531 and 43,142,636 bp on chromosome 9, immediately downstream 
of sestd1 and upstream of ttn.2. The direction of the arrows indicates the direction of 
the genes on the reverse DNA strand. 3 isoforms are indicated for ccdc141: ccdc141-
201, ccdc141-202, ccdc141-203 with 25, 4, and 2 coding exons, respectively. 
Adapted from https://zfin.org/action/mapping/detail/ZDB-GENE-081104-472 
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III. Toxicology 
Maternal exposure to environmental chemicals while pregnant, particularly in the first 
trimester, has been shown to increase the risk of CHDs in their children (7). Thus, both genetics 
and environmental factors contribute to cardiac developmental disruptions and CHDs. Chemicals 
and toxins present in the environment can affect gene expression by interrupting biological 
processes like DNA methylation, leading to defects in heart formation (19). Man-made 
contaminants are ubiquitous within our environment, deriving from a variety of origins including 
the burning of fossil fuels and organic matter, incomplete combustion of crude oil and coal, and 
insecticides and pesticides (20-24). Furthermore, they are often composed of multiple different 
components. For example, pesticides, insecticides, and herbicides are composed of compounds 
like carbaryl, glyphosate, and 2,4-dichlorophenoxyacetic acid (25, 26); emissions from 
automobiles and the burning of fossil fuels are composed of huge amounts of CO2 and other 
compounds with multiple 6-membered carbon rings such as benzo-a-pyrene and phenanthrene 
(23, 27). However, the role of these chemicals in affecting cardiac development in both fish 
populations and in the human population is unknown. Similarly, it is unknown whether particular 
chemicals within a mixture disrupt cardiac development or whether disruption is a result of a 
combination of chemicals. Due to its high genetic and physiological conservation with humans 
and its external fertilization and development, zebrafish are a good model in which to investigate 
these questions. The ability to manipulate the zebrafish genome also make it a good model in 
which to determine the molecular and cellular processes disrupted by chemicals, which lead to 
these physiological defects. As an initial step towards the elucidation of these molecular 
pathogenic pathways, I conducted a literature search compiling a table (Table 1) of chemicals 
and toxins which cause cardiac defects in zebrafish embryos. 
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METHODS 
I. In situ hybridization 
Ia. Collection and Preparation of Embryos 
Prior to beginning in situ hybridization, wild type (wt) embryos at the developmental 
stages 50% epiboly, bud, 3s, 10s, 26 hpf, and 36 hpf were collected. Two wt parents of the same 
line and equal size were transferred to a breeding tank with a divider placed between the fish. 
The tanks were then left overnight, and the divider was pulled the following morning at 
“daylight,” around 8 am. To ensure time and stage of development, embryos were collected 1 
hour later, placed in a petri dish with blue water, and left in the incubator at 28ºC to continue 
development.  
 When the embryos reached the desired stage of development, the chorions of the embryos 
at stages 24 hpf+ were removed (embryos <24 hpf were dechorinated post fixation in 
paraformaldehyde (PFA)) and embryos were placed in 1.5 mL centrifuge tubes. Next, the 
embryos were fixed in 4% fresh PFA overnight at 4ºC. The following day the embryos were 
dehydrated by washing sequentially in 25%, 50%, 75%, and two times in 100% 
MeOH/phosphate buffered solution/.1% tween (PBT) solutions for 10 minutes per solution 
before being placed in a 1.5 mL tube containing 100% MeOH and stored at -20ºC until needed.  
 
Ib. Permeabilization  
 In preparation for ISH, two tubes of approximately 10 embryos per developmental stage, 
one for the control probe and one for the experimental, were rehydrated sequentially in 75%, 
50%, 25% MeOH/PBT for 5 minutes per solution then washed 4x in PBT for 5 minutes at room 
temperature. Next, proteinase K (PK) was added to the embryos to digest the embryos so that the 
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RNA probe can enter the tissue and bind to ccdc141. PK at 10ug/ml was added to embryos at 
stages 24 hpf+. Embryos were left in PK for different times based on the stage of development: 5 
minutes for 24 hpf embryos or 10 minutes for 36 hpf embryos. Embryos <24 hpf were incubated 
in 5 ug/ml PK for 4 minutes. After the addition of PK, embryos were rinsed twice in PBT to 
remove excess PK and fixed in 4% PFA for 20 minutes at RT. Then they were again rinsed with 
PBT 5x for 5 minutes per wash at RT.  
 
Ic. Hybridization 
 After permeabilization by PK, embryos underwent prehybridization for 3 hours at 70ºC in 
65% hybridization solution/PBT (hyb). The hybridization solution contains 50% formamide, 5x 
SSC, 500µg/ml yeast RNA, 50 µg/ml heparin, 0.1% Tween, and 9 mM citric acid. Following 
that, 7 µL of both the ccdc141 and myl7 probes were added separately to 200 µL 100% hyb and 
incubated for 20 minutes at 70ºC; the ccdc141 probe was then added to one tube of embryos and 
the myl7 probe was added to the other. Next, the embryos were hybridized overnight 16-24 hours 
at 70ºC.  
 
Id. Probe Detection [blocking/antibody binding] 
 In preparation for blocking and antibody incubation, the hybridized embryos underwent a 
series of washes in the following order at 70ºC for 15 minutes each: 75% hyb/25% 2x saline-
sodium citrate (SSC); 50% hyb/50% 2x SSC; 25% hyb/75% 2x SSC; and 2x SSC. Next, the 
embryos were washed twice for 30 minutes in 0.2x SSC at 70ºC. Following that was another 
series of washes performed in the following order for 5 minutes each at RT: 75% 0.2x SSC/25% 
PBT; 50% 0.2x SSC/50% PBT; 25% 0.2x SSC/75% PBT, 100% PBT. Embryos were then 
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blocked in a blocking buffer, which contains 5 mL PBT, 2mg/ml BSA, and 5% (0.25 mL) sheep 
serum, for 1 hour at RT. Next, 100 µL of the antibody anti-DIG-fab at a 1:5000 concentration 
was incubated in blocking buffer overnight at 4ºC. Digoxigenin and anti-DIG-fab were used as 
the label and antibody, respectively, because these have high specificity and reduce background, 
making them ideal for in situ hybridization (sigma). 
 
Ie. Staining and Imaging 
 For the final stages of ISH, embryos were washed 6x for 15 minutes in PBT/BSA and 
then washed 3x with alkaline phosphatase buffer (NTMT) for 5 minutes. NTMT (an acronym of 
the first letter of the 4 ingredients) is a staining buffer containing 0.1M NaCl, 0.1M Tris-Cl, 
0.05M MgCl2, and 0.1% Tween.  Embryos were transferred to clean staining dishes in NTMT 
and a staining solution was added to each well, followed by incubation in the dark at RT. 
Staining was checked every hour. Once the staining had developed and darkened, the embryos 
were then stopped via rinsing in NTMT and fixed in 4% PFA overnight at 4ºC. The next day, 
embryos were cleared by washing 5x in PBT/BSA for 5 minutes and then a 2x wash in MeOH 
for 5 minutes. After the washes, the embryos were incubated in MeOH at RT for 1-several hours. 
Lastly, Benzyl Benzoate:Benzyl Alcohol (BB:BA) clearing solution was added to the embryos 














































































































Figure 4: cDNA template probe sequence. Depicted is the complete 
template probe sequence of ccdc141. The probe is complementary to 
the sequence of ccdc141 and will hybridize with the DNA. After probe 
hybridization, staining of the antibody bound to the probe will show the 

























Figure 5. Flow chart of in situ protocol. Purple boxes indicate collection and 
preparation steps (IIa). Yellow boxes indicate denaturation steps (IIb). Blue boxes 
indicate hybridization steps (IIc). Green box indicates blocking and antibody 
detection step (IId). Orange boxes indicate staining and imaging steps (IIe). Figure 
adapted from (1).  
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II. Literature Search for Toxicants 
 For the literature search on environmental toxicants related to CHD, I used the 
PubMed/NCBI database for researching, the Mendeley program for compiling the articles and 
creating citations, and the ChemDraw software for creating the chemical structures shown in 
Table 1 (28-30). Keywords used for the search are as follows: environmental toxins, congenital 




















Part I: ccdc141 is a gene with little known function, but knowing the specific location(s) and 
developmental stages during which it is expressed can help to elucidate its function. ccdc141 was 
found to be expressed in zebrafish tissues that form and derive from the mesoderm germ layer, 
including those ultimately giving rise to the fully formed heart and the heart itself.  
Part II: We have compiled the published findings of environmental toxicants which disrupt 
cardiac function in zebrafish.  
 
Part I. In situ hybridization reveals location of ccdc141 expression in zebrafish embryos. 
In situ hybridization (ISH) allows for the visualization of gene expression. Thus, we have 
sought to perform in situ hybridization of ccdc141 at different stages of zebrafish development, 
in order to aid in the effort of determining the functional relationship of the gene to zebrafish 
heart development. We sought to analyze ccdc141 expression at the stages: 50% epiboly; bud; 3 
and 10 somite stages; prim-5 and prim-25 stages; and long-pec stage of zebrafish. These stages 
were chosen because they are representative of the gastrula, segmentation, and pharyngula 
periods of zebrafish development. They are important periods in regard to heart development, as 
the heart begins formation in the gastrula period and nearly completes formation by the end of 
the pharyngula period. Cardiac progenitor cells first become evident in the 50% epiboly stage, 
located on either side of the lateral marginal zone of the embryo (13). In the bud and 3s stages, 
cardiac progenitor cells move dorsally toward the midline to reach the anterior lateral plate 
mesoderm (ALPM) and arrive at the embryonic axis by the 10s stage (31). The heartbeat and 
vascular circulation occur by the 26 hpf stage, after the fusion of the two tubular cardiac 
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primordia form the definitive heart tube (31). By 36 hpf, heart looping is complete, and the atrial 
and ventricular boundaries are clearly distinguished (31).  
 
Ia. myl7 expressed in myocardial precursors and myocardium. 
 ISH of myl7 was used as a control because it has a well-known expression pattern in the 
heart. By comparing myl7 expression to that of ccdc141, we can determine if the ISH was 
performed correctly (if myl7 is expressed) or if the experiment was not successful (if there is no 
expression of myl7). ISH of myl7 during cardiac looping in the 24 hpf and 36 hpf stages revealed 
myl7 expression in the atrial and ventricular myocardium of the heart tube (Figure 7).  
 
Ib. ccdc141 is expressed in tissues related to cardiogenesis as well as other tissues. 
 Beginning with the gastrula period, embryos at 50% epiboly exposed to the ccdc141 
experimental probe exhibited expression of the gene in the yolk syncytial layer (YSL) (Figure 
8A-C). The YSL is an important multinucleated extra-embryonic tissue located beneath the 
cellular blastoderm. It plays a vital role in zebrafish development through its involvement in 
coordinated cell movement, morphogenesis of the germ layers, specification of cell identity, and 
cardiac morphogenesis (32, 33).  
At the bud stage, ccdc141 appears to be expressed in the mesoderm of the embryo 
(Figure 8D-F). The mesoderm is one of the three germ layers that gives rise to many structures 
and tissues in the developing zebrafish, including the heart muscle.  
In the 30 minutes of development after the bud stage, embryos enter the 3s stage in which 
ccdc141 was found to be expressed in the polster and the paraxial, or presomitic, mesoderm 
(Figure 8G-I). One of the three domains of mesoderm, the paraxial mesoderm differentiates into 
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the somites, which are blocks of mesoderm that eventually give rise to a variety of vertebrate 
body structures, including the dermis, skeletal muscle, cartilage, tendons, and vertebrae (34, 35).  
Expression of ccdc141 in 10s embryos also was found to occur in specific types of 
mesoderm: the anterior lateral plate mesoderm (ALPM) and the somites (Figure 8J-L). The 
ALPM is a derivative of another of the three domains of mesoderm, the lateral plate mesoderm, 
which forms progenitor cells for several tissue types, including the heart and cardiovascular 
system (36).  
By 22 hours post-fertilization (hpf), the linear heart tube of the zebrafish has formed and 
at 26 hpf, ccdc141 expression was visualized in the somites and the atrial, ventricular, and 
possibly endocardial cells of the heart tube, though it is difficult to differentiate atrial/ventricular 
cells from endocardial cells at the magnifications used in this study (Figure 8M-P) (37). At this 
point, the peristaltic contraction of the heart tube occurs, allowing for blood circulation. 
Furthermore, this stage marks the beginning of cardiac looping, during which the linear heart 
tube begins to form into an S-shaped loop. Expression in the ventricular and atrial 
cardiomyocytes, somites, and head was present at 36 hpf; cardiac looping continues, and the 
atrium and ventricle become distinguishable at this stage (Figure 8Q-R). (Images presented in 
Figure 8A-P are unpublished data from the Bloomekatz lab, not my own, as I was unable to 
image these embryos personally due to the COVID-19 pandemic. However, figures 1-7, figure 
8Q and R, and table 1 are my own). 
Determining the tissues in which ccdc141 is expressed at each stage was done by 
comparing the shape and position of the ccdc141 expression pattern with the known shape of 
those tissues as observed through brightfield microscopy or via the expression of other genes 
known to be expressed in those tissues, such as myl7, which is known to be expressed in the 
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cardiac progenitors within the ALPM (10s) and in the heart (22s-36 hpf). However, further 
analysis such as the double fluorescent ISH is needed to definitely assign the identity of the 
tissues in which ccdc141 is expressed.  
By following the expression of ccdc141 from the 50% epiboly stage to 36 hpf (Figures 6, 
8), we see a clear and consistent pattern of ccdc141 expression in tissues involved in cardiac 
morphogenesis; thus, it follows that ccdc141 may play a role in the development of the heart in 
some capacity, although further study is needed to determine its exact function.  
The information on ccdc141 expression gathered from the study of these stages in 
zebrafish can then be used to facilitate further research into determining the role of ccdc141 in 



































Figure 6. Chart of ccdc141 expression in various tissues. Blue color filled cells 




















Figure 7. Images of myl7 expression in studied stages of zebrafish development. 
(A-B) Expression in the atrial and ventricular portions of the heart, lateral view (A) 
and anterior view (B). (C-D) Expression in the atrial and ventricular portions of the 

















































   
   
   
   



























Figure 8. Images of ccdc141 expression during zebrafish development. (A-C) 
Expression in the yolk syncytial layer (YSL), animal pole (A) and lateral (B, C). 
YSL is visible through the enveloping layer (EVL) and blastoderm, which can be 
clearly distinguished (B, C). YSL, EVL, and blastoderm are designated by black, 
blue, and red arrows, respectively. (D-F) Expression in the mesoderm, anterior (D), 
lateral (E), and posterior views (F). The blastoderm is thicker on the dorsal side of 
the embryo at this stage, indicated by the arrow (D, E). (G-I) Expression in the 
polster (indicated by black arrow) and paraxial mesoderm (red arrow), anterior (G), 
dorsal (H), lateral (I) views.  (J-L) Somites and ALPM expression, dorsal (J), lateral 
(K), posterior (L) views. Bilateral ALPM expression is distinct in (J), indicated by 
arrows. ALPM and somite expression are both visible in (K), and sequential blocks 
of somite expression are visible in (L). (M-P) Expression in atrial and ventricular 
regions of the heart, dorsal (M), lateral (N-P) views. Heart tube is visible just to the 
left of the midline (M). Somites and heart tube visible (O). (Q-R) Expression in the 
head, somites, and atrial and ventricular cardiomyocytes, ventral (Q), lateral (R) 
views. Images A-M, O were all taken at 300x magnification. Images N, P Q, R were 
taken at higher magnification. Images of A-P are Courtesy of Bloomekatz Lab, as the 
COVID-19 pandemic prevented the completion of this project. Images Q, R were 
taken by me.  
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Part II. Toxicology 
 The genetic and environmental components of CHD are highly interrelated and work in 
concert during the progression of heart defects. Duration of toxin exposure, concentration of 
exposure, and stage of development in which exposure occurred all affect the severity of the 
cardiac phenotype. Observed abnormal phenotypes vary among the toxins, but abnormal heart 
looping, ventricular abnormalities, and misplaced heart chambers are among the most common 
phenotypes observed in zebrafish embryos. Here we have compiled a list of toxins identified 
causing cardiac phenotypes in zebrafish embryos and we have highlighted a few more for in-
depth description. Although the presented toxins are known to contribute to CHD, the complete 




 Changes in development caused by ethanol exposure are characterized by changes in 
gene expression, cell localization, and cellular adhesion, resulting in the disruption of several 
stages of cardiogenesis in zebrafish, including, but not limited to, myocardial migration, heart 
looping, and endocardial cushion formation (38). Both duration and concentration of exposure to 
ethanol is important, as increased concentrations and increased time of exposure produce more 
severe abnormalities. Short term exposure prior to cardiac specification or during myocardial 
midline migration does not produce persistent or severe morphological defects. However, once 
cardiac specification or myocardial midline migration is complete, short term exposure may 
cause atypical heart development. Exposure over the entire course of cardiac development results 
 34 
in the most severe abnormal phenotypes, including defects of the atrioventricular (AV) valves 
and abnormal heart looping (Table 1: Row 22) (38, 39). 
Disruption of the expression of genes known to be crucial in cardiac development may be 
the primary factor in producing these defects. Several genes, including hand2, gata5, fgf8a, 
myl7, and vmhc are affected, as are the Bmp and Notch signaling gradients. In control embryos, 
localization of these signaling cells is limited to the atrioventricular canal (AVC), whereas in 
embryos exposed to ethanol, Notch and Bmp signaling cells were present throughout the entire 
ventricle (39, 40). 
 
IIb. Tetrachlorodibenzo-para-doxin (TCDD) 
 TCDD is an aryl hydrocarbon receptor (AHR) agonist. AHR mediates toxicity by 
regulating the expression of genes with functions ranging from olfactory receptor to lipoprotein 
lipase. Without a bound ligand, AHR resides in the cytoplasm in a complex with heat shock 
protein 90, but upon binding of a ligand, like TCDD, the AHR complex undergoes a 
conformational change, allowing it to translocate to the nucleus. Once in the nucleus, the AHR 
complex dimerizes with aryl hydrocarbon receptor nuclear translocator (ARNT). The ARNT 
heterodimer then binds to dioxin response elements (DREs) in the promoter region upstream of 
AHR-responsive genes and directs their transcription (41, 42). Binding of TCDD to AHR results 
in the downregulation of a group of genes responsible for cell division and growth, DNA repair, 
and cell cycle regulation, known as cell cycle gene cluster (CCGC). This downregulation results 
in a reduction in the number of cardiomyocytes, as well as increased expression of bmp4 and 
notch1b, two genes necessary for proper heart valve formation (43, 44). Heart abnormalities 
caused by TCDD are observable at 72 hpf. Abnormal heart looping, reduced ventricle size, and 
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thin, elongated atrium are cardiac morphologies characteristic of TCDD exposure (Table 1: Row 
38) (43).  
 
IIc. Phenanthrene  
 Phenanthrene is an AHR agonist that is ubiquitous in the aquatic environment with well-
known cardiotoxic effects, including arrhythmias and disruption of the later stages of cardiac 
morphogenesis by inhibiting cardiac conduction (45, 46). Phenanthrene exposure disrupts 
expression of genes involved in cardiac morphology, function, and specification such as matrix 
metalloproteinase-9 (MMP-9) whose expression is increased upon phenanthrene exposure, 
altering the basement membrane surrounding the cardiomyocytes and disrupting cell signaling 
(23). Additionally, expression of SERCA2a Ca2+ pump and its direct regulator, tbx5, are both 
decreased. Calcium plays a vital role in myocyte contraction, and decreased expression of these 
genes results in cardiomyocyte dysfunction (46). Morphological cardiac defects such as an 
enlarged ventricle with thin ventricular wall, abnormal heart looping, and misplaced chambers 
are also characteristic of phenanthrene exposure (Table 1: Row 31). 
 
IId. Pyrene 
 Pyrene is a polycyclic aromatic hydrocarbon (PAH) and a weak AHR agonist (Table 1: 
Row 34). Like several other toxins, the cardiotoxicity of pyrene acts in a dose-dependent fashion, 
with more severe abnormalities being directly proportional to increasing concentrations of the 
toxin (24). Exposure to pyrene results in the downregulation of Nkx2.5, a transcription factor 
that plays an essential role in the development of the cardiovascular system and in the 
differentiation of myocardial cells. Expression of bmp2b, an upstream gene of Nkx2.5, was 
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downregulated as well (24). Altered expression of these genes leads to pericardial edema and 
abnormal cardiac looping, along with elongated and misoriented heart chambers in zebrafish 
(Table 1: Row 34).  
 
IIe. Benzo-a-pyrene 
 Like several other PAHs, cardiac toxicity of benzo-a-pyrene [B(a)P] is related to AHR 
binding and the disruption of gene expression. Heart abnormalities occur in a dose dependent 
manner, with increasing concentration of B(a)P leading to a higher frequency of abnormal 
cardiac morphologies, like pericardial edema, bradycardia, and abnormal heart looping (Table 1: 
Row 8) (27). A network of genes responsible for regulating cardiogenesis, listed as follows, were 
disrupted by exposure to B(a)P – the genes prox1, tbx5 and pak2a were downregulated upon 
B(a)P exposure, while ahr1b, cyp1c1, cyp1a1, mmp9, prox1, tbx5, pak2a, and mmp2 were 
upregulated (27). Exposure to B(a)P results in elongated hearts, a thin atrium and small ventricle, 
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Table 1.  Environmental toxins related to congenital heart disease highlighted in 
this study. Toxins are listed alphabetically. Tachycardia and bradycardia are 
abnormally rapid and slow heart rates, respectively. Pericardial edema is the 
accumulation of excess fluid in the pericardial sac surrounding the heart, putting 
pressure on the heart and affecting its ability to contract properly. Arrhythmias are 
abnormal or irregular heartbeats, occurring when the electrical circuit of the heart is 
malfunctioning. Stroke volume (SV) is the amount of blood pumped by the ventricle 
in one contraction. The bulbus arteriosus (BA) is the outflow tract component of the 
zebrafish heart that maintains constant blood flow to the gills, and the sinus venosus 
(SV) is the inflow tract of the heart, delivering blood into the atrium. A 2:1 
atrioventricular (AV) block is a conduction block in the heart that prevents cardiac 
impulse transmission between the atria and ventricle. A thrombosis is a blood clot in 
the circulatory system. A hERG (human ether-á-go-go gene) is a potassium channel 




I. ccdc141 gene expression 
Through the use of in situ hybridization, we observed ccdc141 expression in the yolk 
syncytial layer (YSL) at 50% epiboly stage; mesoderm at bud stage; polster and paraxial 
mesoderm at 3s stage; anterior lateral plate mesoderm (ALPM) and somites at 10s stage; heart 
and somites at 26 hpf stages; and heart, somites, and head in 36 hpf stage. These findings 
indicate that variants/mutations of ccdc141 could be involved in the development of CHDs and 
are important for understanding the role of ccdc141 in heart development because the location(s) 
and time(s) at which a gene is expressed provide insight into its function. For example, if a gene 
is expressed only during development and not in adult organisms, the gene likely only functions 
in development; or if a gene is not expressed in a tissue, it is unlikely to serve a function in that 
tissue. 
Due to time constraints, we were unable to observe the 16s, 22s, 48 hpf and 72 hpf stages 
as originally planned. Studies of the 16s and 22s stages would provide more information on 
ccdc141 expression throughout the segmentation period where growth is rapidly occurring, as 
the presented results provide data on only the first half of the period. These stages correspond to 
a specific time period in cardiac development: 16s when cardiomyocytes are undergoing angular 
movement to perform cardiac fusion and 22s when cardiac fusion has completed. Analysis of the 
48 hpf stage would provide information on the hatching period, and the 72 hpf stage would offer 
data on expression at the last stage of development before the start of the larval period, when 
cardiac trabeculation is starting.  
These results lay a foundation upon which further study of the role of ccdc141 in 
development can be performed. We found that ccdc141 is expressed in both cardiac 
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primordium/ALPM mesoderm and in neural tissue. Expression in the neural tissue is consistent 
with previous studies implicating ccdc141 in neuronal migration; thus, ccdc141 might serve a 
similar function in the ALPM, which is undergoing collective migration towards the midline of 
the zebrafish to fuse and create a single heart. We also found that ccdc141 is expressed in the 
heart and somite tissue, which will become trunk muscle, indicating that ccdc141 may be 
important for musculoskeletal development as well. In light of this information, future ISH 
experiments could be conducted to determine ccdc141 expression in the larval, juvenile, and 
adult periods of development. This would allow for a more thorough and detailed view of 
expression throughout the entire lifespan and, together with the presented data, would help 
determine if ccdc141 is expressed and functioning only in development, or if it plays a role in 
adulthood as well. Results on function can then be extrapolated to humans, as ccdc141 in 
zebrafish is orthologous to that in humans and thus may retain the same function. This use of 
zebrafish as model organisms is a key component in research because it bypasses many of the 
ethical concerns that come with research on humans, which allows us to study diseases and test 
possible treatments in a practical way.  
 
II. Toxicology 
 Through extensive research, a table of 44 known cardiotoxins was compiled to be used in 
the publication of a review chapter, written by the Bloomekatz lab, regarding the genetic and 
environmental components of CHDs (86). The mechanism by which the environmental toxins 
presented induce cardiotoxicity is unknown. In line with the research on the role of toxins in 
developmental abnormalities more broadly, we see that the severity of abnormal cardiac 
 47 
phenotypes is dependent on both the duration and concentration of exposure, as well as the 
developmental stage at which exposure occurs.  
Distinct types and classes of chemicals produce similar phenotypes. For example, 
polycyclic aromatic hydrocarbons (PAHs), like phenanthrene, pyrene, and benzo-a-pyrene, 
disrupt the aryl hydrocarbon receptor (AHR) pathway. AHR is important transcription factor in 
the regulation of toxicity in cells. PAHs act as ligands for AHR, and upon binding, can be 
bioactivated to produce toxic metabolites (87). Phenotypes typical of PAHs include elongated 
hearts and misplaced heart chambers. Pesticides, insecticides, and fungicides also produced 
similar phenotypes; nearly all of these compounds result in pericardial edema, bradycardia, or 
tachycardia. In all of the toxins presented, tachycardia, bradycardia, and edema were the most 
common phenotypes.  
 It is my hope that this table can be used as an at-a-glance reference of environmental 
toxicants that contribute to the development of CHD, as well as a basis for further studies. In 
combining the two parts of my thesis, an interesting line of experimentation could involve 
analyzing the connection between ccdc141 and environmental toxins in CHDs. For example, 
determining if ccdc141 expression through ISH during development is disrupted in zebrafish 
embryos exposed to the cardiotoxins presented in this work. Lastly, future experiments could be 
performed to determine what correlation, if any, exists between toxicant exposure and normal 
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